Unknown

Dataset Information

Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.


ABSTRACT:

Unlabelled

Parkinson's disease is characterized by a loss of dopaminergic neurons in a specific brain region, the ventral midbrain. Parkinson's disease is diagnosed when approximately 50% of the dopaminergic neurons of the substantia nigra pars compacta (SNpc) have degenerated and the others are already affected by the disease. Thus, it is conceivable that all therapeutic strategies, aimed at neuroprotection, start too late. Therefore, an urgent medical need exists to discover new pharmacological targets and novel drugs with disease-modifying properties. In this regard, modulation of endogenous adult neurogenesis toward a dopaminergic phenotype might provide a new strategy to target Parkinson's disease by partially ameliorating the dopaminergic cell loss that occurs in this disorde

SUBMITTER: Morales-Garcia JA 

PROVIDER: S-EPMC4449102 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature